Jeffrey S. Heier insider trades: Ocular Therapeutix (OCUL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | OCUL | ↓ Sell | 10,869 | $7.05 | $77K | Direct | Oct 6, 2026 (4d) |
| Aug 24, 2026 | OCUL | ↓ Sell | 3,296 | $10.78 | $36K | Direct | Aug 26, 2026 (2d) |
| May 26, 2026 | OCUL | ↓ Sell | 3,018 | $8.20 | $25K | Direct | May 28, 2026 (2d) |
| Feb 23, 2026 | OCUL | ↓ Sell | 3,057 | $8.28 | $25K | Direct | Feb 25, 2026 (2d) |
| Nov 24, 2025 | OCUL | ↓ Sell | 3,469 | $12.04 | $42K | Direct | Nov 26, 2025 (2d) |
| Oct 2, 2025 | OCUL | ↓ Sell | 10,502 | $11.04 | $116K | Direct | Oct 6, 2025 (4d) |
| Aug 25, 2025 | OCUL | ↓ Sell | 3,063 | $12.04 | $37K | Direct | Aug 27, 2025 (2d) |
| May 23, 2025 | OCUL | ↓ Sell | 3,024 | $7.18 | $22K | Direct | May 27, 2025 (4d) |
| Feb 24, 2025 | OCUL | ↓ Sell | 3,061 | $6.87 | $21K | Direct | Feb 26, 2025 (2d) |
| Nov 25, 2024 | OCUL | ↓ Sell | 2,948 | $9.01 | $27K | Direct | Nov 27, 2024 (2d) |
| May 12, 2022 | OCUL | ↑ Buy | 15,000 | $3.05 | $46K | Direct | May 16, 2022 (4d) |
| Mar 15, 2019 | OCUL | ↑ Buy | 24,000 | $4.15 | $100K | Direct | Mar 18, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OCUL insiders
Open-market trades in the last 12 months
About Jeffrey S. Heier's insider trades
Jeffrey S. Heier is Chief Scientific Officer at Ocular Therapeutix (OCUL). Since Mar 15, 2019, Jeffrey has reported 2 open-market purchases worth $145K and 10 sales worth $426K on SEC Form 4. In the last 12 months: 5 sales ($204K).
Their filings also include grants and awards (13 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OCUL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.